Gujeratefang Fluorochemicals Q3 Result 2025: Profit increased 57.32 %, reaching 126 million rupees year -on -year

Gujeratefang Fluorochemicals Q3 Result 2025: Gujarat Bang’s fluorescent chemist announced on January 29, 2025 that his third quarter results showed a significant increase in revenue and profits. The company’s first -rate increased by 15.76 % year -on -year, and the profit soared 57.32 %, totaling Bleak126 million. The total revenue of the quarter reached Bleak11.48 million.

However, compared with the previous quarter, revenue fell 3.37 %, and the profit growth rate was 4.13 %. This shows that although the year -on -year growth is strong, it performs differently in the short term.

The company’s sales generally increased by a quarter -quarter quarter of the administrative expenses, an increase of 38.06 % year -on -year, which reflects the challenges facing the management cost of increased operating demand.

In terms of operating performance, operating income increased by 3.23 % of a quarter quarter, an increase of 59.56 % year -on -year, emphasizing the improvement of operating efficiency and income production capacity.

Earns per share in the third quarter (EPS) Bleak11.47, a year -on -year increase of 57.34 %, further proved the company’s strong profitability trajectory.

The fluorine chemists in Gujarat received a return of -3.88 % last week, with a return of 4.48 % in the past six months, and the annual return rate was -15.09 %, indicating that the performance of the stock fluctuated.

As of January 30, 2025, the company’s market value is Bleak38852.855 million, 52 weeks high Bleak4880.95, low point BleakIn 2476, extensive stock performance was shown in the past year.

Among the 12 -bit analysts covering the company, there are many suggestions: 1 analyst gives a strong selling rating, 2 analysts give selling rating, and 7 analysts recommend buying rating rating rating The two analysts have released a strong buy rating. This reflects the consensus suggestion as of the end of January 2025.

Gujeratebon fluorine chemist finance

period	Q3 (FY25)	Q2 (FY25)	QOQ growth	Q3 (FY24)	Annual growth
Total income	1148	1188	-3.37 %	991.74	+15.76 %
Sales/general/management costs total	115	110	+4.55 %	83.3	+38.06 %
Depreciation/amortization	91	90	+1.11 %	71.89	+26.58 %
Total operating expenses	956	1002	-4.59 %	871.41	+9.71 %
Operating income	192	186	+3.23 %	120.33	+59.56 %
Net income before tax	175	172	+1.74 %	110.27	+58.7 %
net income	126	121	+4.13 %	80.09	+57.32 %
Diluted normalization EPS	11.47	10.99	+4.37 %	7.29	+57.34 %

Maintain the quarterly quarter results through our result calendar

Disclaimer: This is a live blog generated by AI, which has not been edited by Livemint employeesEssence